Market Closed -
Other stock markets
|
Pre-market 07:12:55 am | |||
5.27 USD | -7.71% | 5.3 | +0.57% |
May. 02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 02 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 1.02B | Sales 2025 * | 1.14B | Capitalization | 276M |
---|---|---|---|---|---|
Net income 2024 * | -155M | Net income 2025 * | -110M | EV / Sales 2024 * | 0.38 x |
Net Debt 2024 * | 111M | Net Debt 2025 * | 336M | EV / Sales 2025 * | 0.54 x |
P/E ratio 2024 * |
-1.76
x | P/E ratio 2025 * |
-2.5
x | Employees | 1,600 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.65% |
Latest transcript on Emergent BioSolutions Inc.
1 day | -7.71% | ||
1 week | +20.59% | ||
Current month | +180.32% | ||
1 month | +170.26% | ||
3 months | +237.82% | ||
6 months | +148.58% | ||
Current year | +119.58% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | Feb. 20 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 18-03-25 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 22-03-31 |
Marvin White
BRD | Director/Board Member | 61 | 10-05-31 |
Louis Sullivan
BRD | Director/Board Member | 90 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 25 M€ | -1.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 5.27 | -7.71% | 1,764,645 |
24-05-15 | 5.71 | +12.40% | 3,122,530 |
24-05-14 | 5.08 | -5.22% | 3,386,322 |
24-05-13 | 5.36 | +23.22% | 5,891,167 |
24-05-10 | 4.35 | -0.46% | 1,383,223 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+119.58% | 276M | |
+32.36% | 694B | |
+30.05% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.34% | 239B | |
+10.40% | 209B | |
-3.15% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- EBS Stock